Head of Alliance Management & Strategic Integration
- Samantha Wein
- Apr 6
- 2 min read
Updated: Apr 24
A high-impact leader with nearly 20 years of experience specialized in maximizing the value of biopharma partnerships. This executive has successfully built three distinct Alliance Management functions, overseen portfolios exceeding 80 active agreements, and led integration teams for multi-billion dollar M&A transactions across the clinical and commercial spectrum.
Core Competencies
Strategic Alliance Leadership: End-to-end management of joint ventures, co-development, and co-commercialization structures.
Post-Merger Integration (PMI): Expert in disruption-free integration planning, accountable to C-suite stakeholders for global operations alignment.
Portfolio Governance: Establishing Joint Steering Committees (JSCs) and collaborative business systems for publicly traded and venture-backed firms.
Deal Execution & Diligence: Bridging the gap between term-sheet execution and long-term asset value realization.
Key Career Milestones
Function Architecture & Scalability: Built the Alliance and Integration Management (AIM) function for a prominent Rare Disease leader, managing a portfolio of 80+ parent agreements and launching 8 new alliances valued at over $3.5B.
M&A Integration Leadership: Co-led the transition planning team for a $39B acquisition by a global "Big Pharma" entity, ensuring seamless continuity for hundreds of functions and thousands of employees worldwide.
Commercial Asset Management: Directed alliance responsibilities for commercial-stage assets and orphan drugs, including the successful integration of a first-of-its-kind acquisition executed during the COVID-19 pandemic.
AI & Emerging Tech Expertise: Transformed the alliance function for a leading AI-enabled drug discovery biotech, overseeing a $1B+ collaboration with a top-tier global pharmaceutical partner.
Public Company Growth: Established the inaugural alliance management function for a NASDAQ-listed neuro-specialty firm, managing a $6B partnering portfolio spanning 18 programs from preclinical discovery to commercial launch.
"Why Now"
Following a successful tenure establishing a world-class alliance function for a mid-cap leader in the rare disease space, this candidate is seeking a VP or Head of Alliance Management/Business Development Operations role. They are particularly interested in organizations entering a period of rapid scaling, heavy deal-making, or those requiring a "steady hand" to integrate complex acquisitions and optimize high-value partnerships.
Consultant Note: This candidate represents a unique "utility player" for a CEO or CBO—someone who can not only help close the deal but ensure the organization actually captures the value promised in the term sheet. Their experience covers the entire life cycle of a drug, from academic licensing at Harvard-affiliated institutions to global commercialization.
Interested in this candidate? To request a resume or schedule an interview, please book a consultation with our team or contact us directly using the links below.
Comments